T 0782/16 (Rivastigmine/NOVARTIS) of 18.07.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T078216.20170718
- Date of decision
- 18 July 2017
- Case number
- T 0782/16
- Petition for review of
- -
- Application number
- 10179085.5
- IPC class
- A61K 9/70A61K 31/27
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Transdermal therapeutic system for the administration of rivastigmine
- Applicant name
- Novartis AG
Novartis Pharma GmbH
LTS LOHMANN Therapie-Systeme AG - Opponent name
- Easypharm GmbH & Co KG
Acino Pharma AG
Alvogen IPCo S.àr.l
STADA Arzneimittel AG
neuraxpharm Arzneimittel GmbH
SK Chemicals Co., Ltd.
Generics [UK] Limited
Actavis Group PTC ehf
Genericon Pharma Gesellschaft m.b.H.
PENTAFARMA, Sociedade Técnico-Medicinal, SA
TECNIMEDE ESPAÑA Industria Farmacéutica, S.A.
Dr. Reddy's Laboratories (UK) Limited/ betapharm
Arzneimittel GmbH
Biogaran - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 76(1)European Patent Convention R 103(1)(a)
- Keywords
- Divisional application - added subject-matter (yes)
Amendments - added subject-matter (yes)
Reimbursment of appeal fee (no) - Catchword
- Reasons, points 4.1.1 to 4.1.3
- Cited cases
- G 0002/10
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The request for reimbursement of the appeal fee is rejected.